{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:55:37Z","timestamp":1780059337150,"version":"3.54.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,3]]},"DOI":"10.7759\/cureus.89275","type":"journal-article","created":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T12:59:09Z","timestamp":1754225949000},"source":"Crossref","is-referenced-by-count":1,"title":["Statin-Associated Necrotizing Autoimmune Myopathy: Unmasking 3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR) Antibody-Positive Disease After Statin Re-exposure"],"prefix":"10.7759","author":[{"given":"Aurora","family":"Cafuli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosagie","family":"Ohonba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donahue K","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Terner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1515161","article-title":"Statin-associated autoimmune myopathy","volume":"374","author":"Mammen AL","year":"2016","unstructured":"Mammen AL. Statin-associated autoimmune myopathy. N Engl J Med. 2016, 374:664-9. 10.1056\/NEJMra1515161","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000497","article-title":"Statin-associated autoimmune myopathy: a systematic review of 100 cases","volume":"23","author":"Nazir S","year":"2017","unstructured":"Nazir S, Lohani S, Tachamo N, Poudel D, Donato A. Statin-associated autoimmune myopathy: a systematic review of 100 cases. J Clin Rheumatol. 2017, 23:149-54. 10.1097\/RHU.0000000000000497","journal-title":"J Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23854","article-title":"Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies","volume":"48","author":"Mohassel P","year":"2013","unstructured":"Mohassel P, Mammen AL. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. Muscle Nerve. 2013, 48:477-83. 10.1002\/mus.23854","journal-title":"Muscle Nerve"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03278-9","article-title":"Statin-induced autoimmune myositis: a proposal of an \"experience-based\" diagnostic algorithm from the analysis of 69 patients","volume":"18","author":"Gagliardo CM","year":"2023","unstructured":"Gagliardo CM, Noto D, Giammanco A, et al.. Statin-induced autoimmune myositis: a proposal of an \"experience-based\" diagnostic algorithm from the analysis of 69 patients. Intern Emerg Med. 2023, 18:1095-107. 10.1007\/s11739-023-03278-9","journal-title":"Intern Emerg Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach Y","year":"2020","unstructured":"Allenbach Y, Benveniste O, Stenzel W, Boyer O. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020, 16:689-701. 10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas MC","year":"2015","unstructured":"Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015, 372:1734-47. 10.1056\/NEJMra1402225","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.02.017","article-title":"Type 1 diabetes associated autoimmunity","volume":"15","author":"Kahaly GJ","year":"2016","unstructured":"Kahaly GJ, Hansen MP. Type 1 diabetes associated autoimmunity. Autoimmun Rev. 2016, 15:644-8. 10.1016\/j.autrev.2016.02.017","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez I","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-mediated necrotizing myopathy. Curr Rheumatol Rep. 2018, 20:21. 10.1007\/s11926-018-0732-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S197941","article-title":"Statin-associated autoimmune myopathy: current perspectives","volume":"16","author":"Tiniakou E","year":"2020","unstructured":"Tiniakou E. Statin-associated autoimmune myopathy: current perspectives. Ther Clin Risk Manag. 2020, 16:483-92. 10.2147\/TCRM.S197941","journal-title":"Ther Clin Risk Manag"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.34673","article-title":"Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"64","author":"Werner JL","year":"2012","unstructured":"Werner JL, Christopher-Stine L, Ghazarian SR, et al.. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Rheum. 2012, 64:4087-93. 10.1002\/art.34673","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00001-08","article-title":"Bacterial, fungal, parasitic, and viral myositis","volume":"21","author":"Crum-Cianflone NF","year":"2008","unstructured":"Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev. 2008, 21:473-94. 10.1128\/CMR.00001-08","journal-title":"Clin Microbiol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000000975","article-title":"Disease-induced skeletal muscle atrophy and fatigue","volume":"48","author":"Powers SK","year":"2016","unstructured":"Powers SK, Lynch GS, Murphy KT, Reid MB, Zijdewind I. Disease-induced skeletal muscle atrophy and fatigue. Med Sci Sports Exerc. 2016, 48:2307-19. 10.1249\/MSS.0000000000000975","journal-title":"Med Sci Sports Exerc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.6.750","article-title":"Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study","volume":"68","author":"Duyff RF","year":"2000","unstructured":"Duyff RF, Van den Bosch J, Laman DM, van Loon BJ, Linssen WH. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry. 2000, 68:750-5. 10.1136\/jnnp.68.6.750","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2008.07.002","article-title":"Vitamin D and skeletal muscle tissue and function","volume":"29","author":"Ceglia L","year":"2008","unstructured":"Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med. 2008, 29:407-14. 10.1016\/j.mam.2008.07.002","journal-title":"Mol Aspects Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1329197","article-title":"Inclusion body myositis","volume":"32","author":"Dimachkie MM","year":"2012","unstructured":"Dimachkie MM, Barohn RJ. Inclusion body myositis. Semin Neurol. 2012, 32:237-45. 10.1055\/s-0032-1329197","journal-title":"Semin Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen L","year":"2005","unstructured":"Casciola-Rosen L, Nagaraju K, Plotz P, et al.. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med. 2005, 201:591-601. 10.1084\/jem.20041367","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-010-0111-8","article-title":"Inflammatory myopathies","volume":"13","author":"Distad BJ","year":"2011","unstructured":"Distad BJ, Amato AA, Weiss MD. Inflammatory myopathies. Curr Treat Options Neurol. 2011, 13:119-30. 10.1007\/s11940-010-0111-8","journal-title":"Curr Treat Options Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy SM","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al.. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019, 73:e285-350. 10.1016\/j.jacc.2018.11.003","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O'Callaghan A","year":"2018","unstructured":"Selva-O'Callaghan A, Pinal-Fernandez I, Trallero-Aragu\u00e1s E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol. 2018, 17:816-28. 10.1016\/S1474-4422(18)30254-0","journal-title":"Lancet Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/384431-statin-associated-necrotizing-autoimmune-myopathy-unmasking-3-hydroxy-3-methylglutaryl-coa-reductase-hmgcr-antibody-positive-disease-after-statin-re-exposure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T12:59:10Z","timestamp":1754225950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/384431-statin-associated-necrotizing-autoimmune-myopathy-unmasking-3-hydroxy-3-methylglutaryl-coa-reductase-hmgcr-antibody-positive-disease-after-statin-re-exposure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,3]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.89275","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,3]]}}}